OIG Approves Cost-Based Hearing Care Referral Service: A Structuring Roadmap for Paid Referral Networks

Key Takeaways

• HHS-OIG Advisory Opinion 26-18 confirms that qualifying paid referral networks can satisfy the Anti-Kickback Statute safe harbor. Protection depends on strict compliance with all requirements, not simply fixed participation fees.
• Healthcare providers, technology companies, and investors should evaluate cost-based fees, equal participation standards, clinical independence, and documented patient disclosures. Deficiencies may expose arrangements to federal fraud-and-abuse scrutiny.
• Advisory Opinion 26-18 protects only the reviewed arrangement on its certified facts. Organizations must separately assess related financial relationships, state referral restrictions, and other applicable laws before launching or acquiring referral platforms.

OIG Advisory Opinion 26-18: Why the Approval Matters for Paid Referral Networks

The U.S. Department of Health and Human Services Office of Inspector General (“OIG”) issued a favorable opinion concerning a proposed referral service (the “Hearing Referral Service”) connecting patients who need specialized ear and hearing care with groups of audiologists, hearing aid specialists, and ear, nose, and throat specialists (“Hearing Professionals Groups”). Although participating Hearing Professionals Groups would pay to participate in the referral service, OIG concluded that the arrangement would satisfy every condition of the Anti-Kickback Statute’s referral services safe harbor, 42 C.F.R. § 1001.952(f). Accordingly, the arrangement would not generate prohibited remuneration, and OIG would not impose administrative sanctions under the civil monetary penalty and exclusion authorities addressed in the opinion.

The opinion offers a useful structuring roadmap for physician groups, health systems, healthcare technology companies, and investors evaluating paid referral networks. Its central lesson is that every safe harbor element must be met precisely: a fixed annual participation fee alone does not establish safe harbor protection. OIG’s conclusion depended on cost-based fees, uniform participation standards, clinical independence, and documented patient disclosures — not simply the absence of per-referral payments.

How the Cost-Based Hearing Referral Service Operates

The unidentified requestor’s parent company manufactures a handheld ear, nose, and throat device combining digital otoscopy, cerumen removal, and an initial hearing assessment. Primary care clinicians would pay a subscription fee to use the device when treating patients in their practice. When its software identifies hearing results outside normal ranges, the clinician could exercise independent clinical judgment to initiate a referral through the Hearing Referral Service. OIG was not asked to opine on, and expressed no opinion regarding, the financial arrangement between the requestor and primary care clinicians.

Before consenting, the patient would review on-screen information describing the Hearing Referral Service, including notice that the Hearing Professional Group has paid a fee to the requestor to participate in the referral service, then confirm consent and sign. A referral coordinator, a licensed audiologist (or other appropriately trained individual) employed by the requestor, would then confirm that the ear canal was clear before testing, the results were outside normal hearing ranges, and no other concern required attention before referral. Qualifying patients would be referred to a participating Hearing Professionals Group, which would select a professional based on the patient’s ZIP code and report treatment outcomes back to the referring clinician. The requestor would neither discount primary care subscription fees based on referral activity nor impose exclusivity requirements or minimum referral expectations on primary care clinicians. These referrer-side safeguards help ensure that the device arrangement does not function as a reward for referrals, although OIG did not opine on that relationship.

Each participating Hearing Professionals Group would pay an annual participation fee established in advance, unrelated to the number of referrals received or whether referred patients obtained care. Fees would reflect estimated operating costs and, where multiple groups participated, would be apportioned equally based on the number of professionals affiliated with each group, so that total collections remain aligned with estimated operating costs. The first-year fee would be prorated. An annual reconciliation (the “True-Up”) would compare actual aggregate costs, including software maintenance, labor, and administrative overhead, with projections and adjust the following year’s fee upward or downward so the service is neither subsidized nor profit-generating from referral volume. The requestor would maintain detailed records of each True-Up calculation.

The principal legal framework was the federal Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b) (Social Security Act § 1128B(b)), which prohibits knowingly and willfully exchanging remuneration to induce or reward referrals or other specified business involving federally reimbursable items or services. The request also addressed the related civil monetary penalty and permissive exclusion authorities, 42 U.S.C. §§ 1320a-7a(a)(7) and 1320a-7(b)(7) (Social Security Act §§ 1128A(a)(7) and 1128(b)(7)). The opinion addresses only the Anti-Kickback Statute and these related penalties, not other fraud-and-abuse laws (see the limitations discussed below).

How the Referral Service Satisfied the Anti-Kickback Statute Safe Harbor

OIG first determined that the arrangement implicated the Anti-Kickback Statute: participating Hearing Professionals Groups would pay the requestor to receive referrals for potentially federally reimbursable services. It then concluded that the fees qualified for protection under the referral services safe harbor. This distinction matters. OIG found full safe harbor compliance, rather than merely exercising enforcement discretion over an otherwise unprotected arrangement. Safe harbor compliance means the payments are not treated as remuneration at all, rather than being tolerated on a case-by-case basis.

The safe harbor imposes four standards. First, the service may not exclude any participant meeting its qualifications. The requestor certified that it would apply its participation criteria equally to all Hearing Professionals Groups. Under those criteria, a group must employ or manage the practice of its professionals, each professional must hold a current state license, and the group must maintain proof of licensure. A professional would be removed if the professional leaves the group (and does not immediately join another participating group), loses licensure, is the subject of malpractice findings or quality concerns, is excluded from federal healthcare programs, or fails to follow contractual protocols, such as consistently failing to complete outcome reports. Notably, the requestor will initially contract only with groups that credential their professionals and plan to admit independent professionals once a quality-control program is in place. The opinion suggests that phased or tiered criteria can coexist with open participation if they are objective and applied equally. Second, participant payments must be assessed and collected equally, reflect only the cost of operating the service, and remain unrelated to the volume or value of referrals or other federally reimbursable business generated between the parties. OIG accepted the certified fee methodology and True-Up as satisfying that standard.

Third, the service generally may not dictate how participants furnish care, subject to the regulation’s limited exceptions for certain patient charges. Here, the requestor would impose no clinical protocols, product restrictions, including hearing aid brand requirements, or pricing demands. The arrangement does, however, require outcome reporting. In practical terms, requiring participants to report outcomes is permissible; dictating protocols, products, or prices is not.

Fourth, the service must make five specific disclosures to each person seeking a referral:

1. how it selects the group of participants to which it could refer;
2. whether the participant has paid a fee;
3. how it selects a particular participant for that person;
4. the nature of the relationship between the service and its participants; and
5. any restrictions that would exclude a participant from continuing in the service.

Each disclosure must be preserved in a signed written record certifying the disclosure. The regulation permits signature by either the person seeking the referral or the individual making the disclosure; the reviewed arrangement used patient signatures. OIG concluded that all five disclosures would be made and documented.

On these certified facts, OIG concluded that the arrangement would not generate prohibited remuneration and that OIG would not impose administrative sanctions on the requestor under the civil monetary penalty and exclusion authorities. The opinion applies the existing safe harbor rather than announcing a new exception or relaxing its conditions. OIG reiterated that safe harbor protection requires precise compliance, while arrangements outside a safe harbor remain subject to case-by-case evaluation.

OIG Opinions 26-18 and 26-15: Why Fixed Referral Fees Receive Different Treatment

Opinion 26-18 should be read alongside Advisory Opinion 26-15, posted June 30, 2026, in which OIG issued an unfavorable opinion regarding a home health agency’s payments to a vendor for use of subscription-based online referral management software. Read together, the two opinions show that a subscription or flat-fee structure is not itself protective. What distinguished the favorable outcome in 26-18 was strict alignment of fees with operating costs, equal assessment across participants, open participation, clinical independence, and documented patient disclosures, each tied to the elements of the referral services safe harbor. Operators of referral technology platforms should expect OIG to look past the label of a “software” or “subscription” fee to whether the payment is, in substance, compensation for referrals.

What OIG Advisory Opinion 26-18 Means for Healthcare Providers, Platforms, and Investors

For provider networks and referral platform operators, the practical priority is to distinguish a cost-recovery referral service from a commercial patient-acquisition model. A fixed annual participation fee is insufficient if its calculation includes amounts beyond operating costs or reflects anticipated referral opportunities. Clients seeking this safe harbor’s protection should document the cost methodology, allocate expenses consistently, prorate partial-year fees, and maintain True-Up records. The opinion supports a prospective annual adjustment mechanism on its particular facts; it does not endorse every allocation methodology or commercial pricing model.

Participation rules and patient-facing processes deserve as much attention as fee design. Operators should use objective, consistently applied eligibility and removal criteria and assess whether contractual preferences or selective admission undermine open participation. Where multiple participants are available, operators should also adopt and document a neutral method for selecting which participant receives a given referral — for example, geography or rotation. The safe harbor requires disclosure of that method, and the opinion describes only how a group selects an individual professional by ZIP code, not how the coordinator chooses among multiple groups. Patient consent should be accompanied by the five required disclosures and retained signed records. For device manufacturers and other life sciences companies, the reviewed arrangement’s prohibition on product restrictions is especially significant: safe harbor protection for the referral service should not be assumed to extend to a network designed to steer downstream product selection.

Hospitals, physician groups, and private equity sponsors should also examine interconnected financial relationships separately. OIG did not review the primary care subscription arrangement, and its favorable conclusion does not validate an entire technology-enabled business model. Diligence should distinguish referral-service participation fees from device subscription charges, marketing services, and other payments, then evaluate each relationship under the applicable law.

Clients should also evaluate state-law exposure. The opinion expressly declines to address state law, and many states have patient-brokering, fee-splitting, anti-kickback, and professional licensing rules that may apply to paid referral services regardless of federal safe harbor status — in some cases including arrangements involving only commercially insured or self-pay patients. Operators should review the laws of each state in which referred patients or participating professionals are located before launch.

Finally, only the requestor may rely on the opinion, and only on the certified facts. The opinion binds HHS but no other federal agency. It does not protect other parties or arrangements and does not resolve physician self-referral, other federal or state law, or False Claims Act issues. Other organizations may draw useful analytical guidance from the opinion, but must establish their own compliance rather than rely on another party’s approval.

What Healthcare Referral Network Operators Should Do Now

Advisory Opinion 26-18 demonstrates that a paid, technology-enabled referral service can obtain Anti-Kickback Statute safe harbor protection when its economics, participation rules, clinical boundaries, and disclosures satisfy the regulation. Organizations developing or investing in comparable networks should assess those elements, and applicable state law, before launch and revisit them as operations evolve.

Please contact AGG Healthcare attorneys Michael Barry or Maggie Callahan with questions regarding this opinion or for assistance evaluating referral platforms, participation agreements, fee methodologies, and related healthcare transactions.